Cancer is seen as an abnormal medical condition having as main causes some factors such as the genetic inheritance, because cancer can be inherited by the members of the same family, the aging process, the working environment, alimentation, excessive alcohol drinking and smoking or even race.
<-336x280 Large Rectangle - center->
The causes mentioned above allow the multiplication and the fast spreading of the cancer cells, first in the infected organ and only after in the entire body. The normal apoptotic reaction and the mitosis fail to function well and because of that the primary tumor slowly increases in size and eventually reaches outside the organ confined site. With these features we can also describe the cancer that affects the male specific gland responsible with the making of the seminal fluid, the prostate.



Usually, the spreading process is done by invading the surrounding areas of the prostate, in the first stages the cancer becoming locally advanced and without any proper treatment the cancer will soon become metastatic; that basically means that the cancer cells started their travel to other far regions of the organism through the bloodstream and the lymph system and made possible the apparition of other small, secondary malignant tumors which can infect vital organs such as the lungs or brain.

Each cancer is unique and different patients may report different symptoms in different stages in different periods of time; the prostate cancer has no early signs to make it noticeable in its first stages but there are some common reported symptoms which tend to appear soon after starting its spreading. If any unusual symptoms are noticed without any specific and unidentified cause then the screening tests are recommended. No matter how old this approach of identifying the prostate cancer in its early stages may be the screening tests still remain popular.

The screening includes the digital rectal examination done by a medical specialist that determines any abnormality with the size of the prostate gland by inserting a gloved finger into the rectum and palpating the presumably infected organ; the prostate specific antigen blood test indicates the levels of the prostate specific antigen protein which in normal circumstances should be low. The results of these tests have to be interpreted by doctors; they will also be responsible for the decision to continue with the medical investigations or not.

With the help of the prostate biopsy the future diagnose will be as accurate as it can be, especially if this method of detection is complemented by newer ones such as the nomogram or the prostate mapping.



If cancer is detected the main problem will be to answer the question of how long do men with advanced prostate cancer get to live. First, the characteristics of the prostate cancer will be determined with the grading and staging systems such as the Gleason scale and the TNM (tumor, nodes and metastatic) staging system or its alternative, the Whitmore-Jewett system.

Usually the higher a score is the more aggressive a cancer can get so it is very important to make an accurate prognosis about the outcome of the prostate cancer and determine approximately how long men could live with an advance prostate cancer.

Usually the prognosis has two results: the patient will respond well to the treatment or the prescribed treatment will prove ineffective in stopping or even delaying the spreading of the tumor. The prognosis is usually challenging just because its results are relative,

depending very much on the uniqueness of each cancer but the mortality charts offer some answers about the chances of survival and for how long a patient gets to live if he is diagnosed with an advanced prostate cancer.

Even after the five year survival rate a possibility of cancer recurrence will always remain, sometimes coming back in more aggressive forms such as the metastases or two or more metastatic tumors, affecting gravely the bone system and other important organs.

To prolong the chances of survival or living for men with advanced prostate cancer the recommended treatments are the radiotherapy, brachytherapy or proton beam therapy, the androgen deprivation therapy or the hormone therapy and chemotherapy, complemented by the use of strong drugs to increase the treatment’s effectiveness.

After fifteen years the survival rates tend to stabilize and the life expectancies can increase even if the cancer is locally advanced but for the metastatic cancer, the average time of survival is one to three years after the initial diagnose and sometimes the patient will die because of some other health complications.

The mortality charts based on annual information about the survival rates from prostate cancer indicate a large number of deaths caused by this type of cancer, although the newer methods of detection prove to be more efficient in establishing a correct diagnose.
<-336x280 Large Rectangle - center->
That doesn’t necessarily mean that the screening tests are inefficient. In fact, the screening tests only indicate an abnormality with the prostate organ; the digital rectal exam done by inserting a gloved finger into the rectum to palpate the size of the prostate can easily indicate any whether a lump or a hardness is felt on the surface on it. The prostate specific antigen blood tests indicate the levels of the prostate specific antigen protein, which should be low in normal conditions. The results of the screening tests have to be interpreted by medical specialists who will eventually decide if the medical investigation should continue or not.

In most of the cases the prostate cancer isn’t noticeable in its first stages since it has so early signs or symptoms. When the primary malignant tumor starts its spreading to other regions of the body and the cancer cells have entered the bloodstream or the lymph system and travel to vital organs such as the lungs and brain, where they will allow the developing of other small and secondary tumors until the cancer becomes metastatic, the patient will report some unusual symptoms.



As old as it may be, the screening test still remains the best method of detecting the cancer in its early stages.

For an accurate result, the prostate biopsy is complemented by some newer methods of detection such as the prostate mapping or the nomogram.

Based on the charts of prostate cancer mortality the prognosis for the outcome is not so optimistic, rather it is well know the fact that every year, around the world, one in six men gets to be diagnosed with a prostate cancer and only the lung cancer causes more deaths than the prostate cancer.

Cancer is seen as an abnormal condition having as main causes some factors such as the working environment and the alimentation, the smoking or excessive alcohol drinking, the ageing process, the genetic inheritance since cancer can be inherited via the members of a family and even race. These factors allow the fast development or multiplication of the cancer cells while the normal ones experience a rapid death because of the malfunctioning of the apoptotic reaction and the mitosis.

The prognosis gets challenging because each cancer is unique and that means that the same type of cancer can develop in different people at different stages, in different periods of time with different effects on the general health of that certain patient.



The mortality statistic charts help the medical specialists determine some of the prostate cancer characteristics such as its progression or evolution in different people in different regions of the world and search for treatment alternatives.

Usually the prognosis has two results: either the patient will respond well to the prescribed treatment, no matter what the stage of his cancer is, or the treatment will prove inefficient to stop or even delay the progression of the prostate cancer.

In America as well as in some parts of Europe like Great Britain, the survival rate of five year after the initial diagnose if of about ninety eight percent while the one for ten year survival rate is of ninety one percent. The chances or survival increase if the cancer is detected in its early stages and after the fifteen survival trial the results tend to stabilize and there is even the chance of curing the cancer. Usually, the cancer recurrence happens in the next five years after the initial treatment; after this period of time the chances of recurrence drop.

The fifteen year survival rate is of about seventy six percent but if the cancer becomes locally advance or metastatic, life can be prolonged only with the help of some strong and effective treatment such as the hormone therapy or radiotherapy.

The lifetime probability of developing a prostate cancer is about sixteen percent and the results indicated by the mortality charts can only increase the angst and the depressive moods of a patient if they are revealed.

For example, in America, by the beginning of the year 2009, it was estimated that almost two thousand cases of prostate cancer will be diagnosed while almost thirty thousand patients will die because of it. The positive news is that almost two million Americans diagnosed with prostate cancer are still alive today.

Cancer is seen as an abnormal condition having as main causes some factors such as the working environment and the alimentation, the smoking or excessive alcohol drinking, the aging process, the genetic inheritance since cancer can be inherited via the members of a family and even race. These factors allow the fast development or multiplication of the cancer cells while the normal ones experience a rapid death because of the malfunctioning of the apoptotic reaction and the mitosis.
<-336x280 Large Rectangle - center->
In most of the cases the prostate cancer isn’t noticeable in its first stages since it has so early signs or symptoms. When the primary malignant tumor starts its spreading to other regions of the body and the cancer cells have entered the bloodstream or the lymph system and travel to vital organs such as the lungs and brain, where they will allow the developing of other small and secondary tumors until the cancer becomes metastatic, the patient will report some unusual symptoms.



The screening tests indicate an abnormality with the prostate organ; the digital rectal exam done by inserting a gloved finger into the rectum to palpate the size of the prostate can easily indicate any whether a lump or a hardness is felt on the surface on it. The prostate specific antigen blood tests indicate the levels of the prostate specific antigen protein, which should be low in normal conditions. The results of the screening tests have to be interpreted by medical specialists who will eventually decide if the medical investigation should continue or not.

For an accurate result, the prostate biopsy is complemented by some newer methods of detection such as the prostate mapping or the nomogram.

The lifetime probability of developing a prostate cancer is about sixteen percent and the results indicated by the prostate cancer world wide statistics can only increase the angst and the depressive moods of a patient if they are revealed.

For example, in America, by the beginning of the year 2009, it was estimated that almost two thousand cases of prostate cancer will be diagnosed while almost thirty thousand patients will die because of it. The positive news is that almost two million Americans diagnosed with prostate cancer are still alive today.

In America as well as in some parts of Europe like Great Britain, the survival rate of five year after the initial diagnose if of about ninety eight percent while the one for ten year survival rate is of ninety one percent. The chances or survival increase if the cancer is detected in its early stages and after the fifteen survival trial the results tend to stabilize and there is even the chance of curing the cancer. Usually, the cancer recurrence happens in the next five years after the initial treatment; after this period of time the chances of recurrence drop.

The mortality statistics for prostate cancer patients help the medical specialists determine some of the prostate cancer characteristics such as its progression or evolution in different people in different regions of the world and search for treatment alternatives.



Usually the prognosis has two results: either the patient will respond well to the prescribed treatment, no matter what the stage of his cancer is, or the treatment will prove inefficient to stop or even delay the progression of the prostate cancer.

Based on certain surveys or statistics of prostate cancer the prognosis for the outcome is not so optimistic, rather it is well know the fact that every year, around the world, one in six men gets to be diagnosed with a prostate cancer and only the lung cancer causes more deaths than the prostate cancer.

The statistics about the prostate cancer based on annual information about the survival rates indicate a large number of deaths caused by this type of cancer, although the newer methods of detection prove to be more efficient in establishing a correct diagnose.

The prognosis gets challenging because each cancer is unique and that means that the same type of cancer can develop in different people at different stages, in different periods of time with different effects on the general health of that certain patient.

Every year, all around the world, one in six men gets to be diagnosed with a prostate cancer while in America, the prostate cancer is on the second place, after the lung cancer, responsible for the deaths of hundreds of men.
<-336x280 Large Rectangle - center->
The prostate is a male specific organ, responsible with the making of the semen, so usually, after the age of forty, when all men experience the so-called “andropause” or “male menopause”, any hormonal problems and unbalances may lead to the apparition of some prostate disorders and diseases such as prostatitis, the benign prostatic hyperplasia and cancer.



Cancer is diagnosed only when the existence of cancer cells or a malignant tumor is detected and since there are no early symptoms to make this disease noticeable in its early stages, the screening tests are often recommended.

The results of the screening tests have to be interpreted by doctors because they don’t give an accurate diagnose whether the cancer exists or not or if it is organ confined or locally advanced. For example, with the digital rectal exam the physician will palpate with a gloved finger inserted into the rectum the size of the prostate and determine whether an abnormal lump or hardness is felt on the surface of the presumably infected gland and the prostate specific antigen blood tests can only indicate the level of the prostate specific antigen protein, which should be low in normal circumstances, making this test a tumor and biological marker.

If cancer is detected early, the survival rates can only increase, especially if the patient responds well to the prescribed treatment.

An accurate diagnose can be obtained only with the help of the prostate biopsy complemented by a nomogram or the prostate mapping method.

The prognosis is relevant in the cases when doctors wish to determine the characteristics of a cancer; unfortunately, each cancer is unique and that means that the same type of cancer could develop in different periods of time, at different stages in different patients, with different treatment results, making the prognosis challenging.

The chances of fifteen year survival rate are of seventy seven percent and usually after this period of time the survival rates tend to stabilize; the lifetime probability to develop cancer is of sixteen percent and if cancer is detected early there is a ninety eight percent chance of survival at least for five years after the initial diagnose.

If cancer is detected, the grading and staging will be very important for prescribing the right form of treatment. The staging is done with the Whitmore-Jewett staging system or the TNM, tumor, nodes and metastatic system; according to these systems there are four stages of prostate cancer the last being the stage of metastatic cancer.

The apparition of a prostate cancer depends on certain factors such as the aging process, race and genetic inheritance and even the working environment; the progression of a prostate cancer is done steadily, the tumor doubling its size once every four years.

The spreading process is done through the lymph system and bloodstream until the primary tumor, in the first stage being organ confined, affects the surrounding organs and tissues and gives birth to other secondary and small tumors. These tumors can become metastatic and affect vital organs such as the liver, lungs and brain.

The prostate cancer has the predilection of affecting gravely the bone structures so even though the signs of a prostate cancer tend to appear only when the cancer beings its evolution the bones can be affected even in the first stages. If some unusual bone pains are felt this is a definitive sign that a person must immediately contact his personal doctor. The radionuclide bone scans, the coaxial tomography or the magnetic resonance imaging or MRI can confirm if the cancer has spread to the bone system or not and in general the bone lesions are osteoblastic, osteolytic or mixed.



The two major prognosis for the outcome of the prostate cancer indicate a challenging treatment or the patient will respond well to the treatment; for the locally advanced cancer the survival rates can be prolonged but the metastatic cancer will prove merciless and the chances of survival, even with a proper treatment such as the hormone therapy or radiotherapy, will drop at low levels.

Cancer is not a typical disease but a rather common one and is often seen as an abnormal medical condition which occurs whenever the apoptotic reaction and the mitosis, or is simpler words, the normal division and death of a cell, are interrupted or stop functioning, leading to an increase in the number of the cancer cells and the apparition of a malignant tumor.
<-336x280 Large Rectangle - center->
The spreading process is done through the lymph system or the bloodstream, when the cancerous cells have escaped from the prostate capsule and entered the blood vessels to reach and infect far distanced organs and tissues, sometimes the vital organs such as the lungs or brain.



These general features can be found in all types of cancer, especially the prostate cancer.

This cancer affects only the prostate gland, which is responsible for the making and storing of the semen, obviously being an organ specific to the male reproductive system.

There are no early symptoms to make the prostate cancer noticeable in its early stages but according to certain surveys, one in six men will get to be diagnosed with a prostate cancer in his lifetime.

The more advanced the cancer is, the more difficult the treating could be and this is the main reason why doctors recommend the routinely screening tests to identify any signs of cancerous cells; with the digital rectal exam the physician palpates the prostate to feel its size; the prostate specific antigen blood test is a tumor marker and with it doctors can determine the levels of the prostate specific antigen, which in normal circumstanced should be low. In other words, these tests don’t actually show the existence or non-existence of a malignant tumor; rather doctors have to interpret the results and decide whether the medical investigation should continue or not. If the results are abnormal, the prostate biopsy, complemented with a new method of detection, the prostate mapping, will give an accurate diagnose.



The cancer survival statistics or survival rates identify the percentage of patients who survive a certain type of cancer for a determined amount of time. These cancer statistics use a five year survival rate and as an example, the determined five years survival rate for people diagnosed with prostate cancer is of ninety eight percent and that basically means that 98 out of 100 men were still living five years after the initial diagnose or two our of 100 men had died in this survival period of time because of the prostate cancer.

The five year survival rate includes men of all health conditions and ages, as well as those diagnosed very early or some very late. Some types of survival rates offer accurate information about the progression free survival rate or the number of people who are affected by cancer but their disease isn’t progressing, including those who had responded well to the prescribed treatments and the disease free survival rate or the number of men who achieved remission or the cancer had been completely cured.

The survival statistics can be used by doctors to understand better your prognosis or your chances to achieve remission, depending also on other factors such as age and general health and to develop a treatment plan, depending of the treatments results obtained by other patients with the same stage and type of cancer as your own. This decision also depends on other factors such as the number of side-effects, the general pros and cons of each treatment alternative, etc.

The survival rates or statistics are based on hundreds of people with the similar cancer characteristics but things can get a little frustrating because, as I’ve mentioned before, each cancer is unique and all these results are relative and can only give you a general idea of how this disease evolves in people with similar types of cancer as yours but no survival rate can give an accurate response about who will your cancer progress.

The survival rates are very important when you have to decide for a treatment option and can give you some information about the latest treatments.



You can choose to ignore these survival characteristics but the best thing about them is that they can lessen your anxieties; the worst part is that they are confusing and frightening and can generate some unhealthy ideas.

The help a doctor can give is irreplaceable so always seek for his advice if you still have some unanswered questions about the prostate cancer.

There are some useful sites maintained by prostate cancer survivors and meeting groups to discuss new ways of prevention and treatment. There are many foundations that at a national or regional level give conferences in programs for informing people about prostate cancer. The sites that have that information are a great resource both for male patients suffering from prostate cancer and their wives who will learn how to deal with this new situation in their lives.
<-336x280 Large Rectangle - center->
One great resource of information is the experience of men who suffered prostate cancer and got cured. Their story can be a great help for men who got diagnosed with this form of cancer because they will see there is hope and depending the stage of their cancer there is a great chance for curing and surviving it.

There are prostate cancer survivors who have published their experience with all this mean from preliminary test, going to a specialist to prescribe the right treatment. How their personal lives changed. What financial ways they have found to be able to finish the treatment. The man who was diagnosed with prostate cancer can look up for blogs, forums, and even personal websites that have information. Many of prostate cancer survivors put on their sites links to reliable Cancer treatment centers and effective ways of treatment. Reading the experience of others is a great way to find new ideas to cope with prostate cancer.

Here are just a few of the sites where you could find testimonials from different people http://www.mdjunction.com/prostate-cancer, http://pcjournal-rrd.blogspot.com/, http://www.thecancerblog.com/2006/08/15/prostate-cancer-survivor-blogs-the-cancer-diary/. Personal experience of prostate cancer survivor can be a good help for other men recently diagnosed with this or with risk of developing prostate cancer.

Prostate cancer survivors are glad to share what they have to do in order to get the right treatment that cured their prostate cancer. Other useful things you could find on some sites that have diaries of men who survived t are also information about the healthy diet that helps prevent the development of prostate cancer. The diet can be a risk factor for developing prostate cancer, another one is the genetic factor if in a family one member suffered prostate cancer it is possible that the cancer to develop.

Wives or partners or sisters of men who are diagnosed with prostate cancer or that have diagnosed with the risk of developing the prostate cancer can find useful information how to deal with this situation in their lives. They will know what to ask when they will go with their partners to a Cancer center and what treatments are available in their area. From the diary of a cancer survivor you can get also the real review of a Health center.

If one had a bad experience with a Health center won’t hold this experience just for him and will tell to friends, write on the blog or on sites that gather cancer experts and patients. Don’t follow the treatment you find on a webpage because it might not work in your case. Ask your physician and do the test to find the right treatment for you.

It has been estimated that 234.000 new cases of prostate cancer will be diagnosed in the United States of America next year. This leads us again to the conclusion that prostate cancer is the most common cancer type among American men, excepting for skin cancer. More than 27.000 deaths because of prostate cancer are expected to occur next year.

<-336x280 Large Rectangle - center->

The good news is that the outlook for men diagnosed with this type of cancer is better than it has ever been. More than half of all prostate cancers are found in early stages, while the tumor is still localized, and the five year survival rate for these men is 99 percent.

The prostate is a gland about the size of a walnut that is situated near the urinary bladder and in front of the rectum. The urethra passes through the prostate. The prostate gland produces a fluid that serves as the vehicle for sperm. Although there might be implications if the prostate gland is removed through surgery, it is not an essential organ and the body can function just as good without it.

Many men, especially as they get older, are affected by an overgrowth of prostate tissue. Many times, this tissue overgrowth is benign, which means that the cells do not contain cancer. This prostate condition is called benign prostatic hypertrophy, and it is also known as BPH. Other times, abnormal cancerous cells characterize the overgrowth of the tissue, and this is referred to as a malignancy or cancer of the prostate. Prostate cancer is one of the most controversial cancers in both diagnosis and treatment.

Facts on prostate cancer - Prostate cancer is more aggressive For Afro American people than for Caucasian people; This is the second commonest cancer which affects men, after lung cancer; The risk of developing prostate cancer grows after the age of 50. The majority people who have been diagnosed with prostate cancer are men over 65 years; There are over 2 million American men currently living and dealing with prostate cancer;

Charles B. Huggins was awarded a Nobel Prize for understanding that prostate cancer was dependent on testosterone for its growth in 1941. He also proven that it spreads and this could be reversed by giving estrogens, which is the so called ‘Chemical Castration’; Prostate Specific Antigen is a marker for diagnosing prostate cancer and it was first used in forensic investigation to determine if a stain on the undergarment was due to semen or not;

The use of ‘robotics in surgery’ is most commonly deployed for removing a malignant prostate cancer from the pelvis; Prostate cancer is a relatively slow developing cancer. For all stages of the cancer the average five year survival rate is 98% and the ten year survival rate is 84%; Most people die having this type of cancer and not because of prostate cancer. Other facts on prostate cancer are that the survival chances for people diagnosed with prostate cancer have improved over the years and doctors and researchers are sure that their work is leading to success in treating this disease.

A study, the first of this type, conducted by a team of specialists of the Tropical Hygiene and Medicine school of London, on 1.9 million people in 31 countries, over 20 in Europe, USA, Canada, Australia, Brazil, Japan, Algeria and Cuba, shows that prostate cancer survival rates differs from one country to another. For example, in the USA are registered the best percents, especially among Caucasians.

<-336x280 Large Rectangle - center->

Scientists compared the prostate cancer survival rates of 5 years between 1990 and 1994. Generally speaking, taking into account all cancer types, the best survival rates were registered in North America, followed by Australia, Japan and Occidental Europe. The smallest survival rates were registered in Algeria, where the scientists could only conduct their studies in the region of Setif.



As for breast and prostate cancer, the best survival rates were registered in the USA. Japan has the best survival rates for colorectal cancer in men, and France- for colorectal cancer in women. The five year survival rate varies from 11.4% in colorectal cancer in men to 38.8% in breast cancer. In the USA, the numbers go from 56.4% in colorectal cancer in men to 91.1 % in prostate cancer. In France, the survival rates go from 52.8% in rectal cancer to 79.8% in breast cancer.

The most significant survival rates are between Occidental Europe, with less than 40% in prostate cancer in Denmark and 80% in Austria for the same type of cancer. In the USA, the survival rate for Afro- Americans than for Caucasians, with a difference of 7% for prostate cancer and 14% for breast cancer. Scientists believe these differences are caused by diagnosis and treatment of doctors.

The presence of three genetic defects influences the prostate cancer survival rates, diminishing the survival rate after the installment of the disease. Because at the time of the diagnosis the doctors are not aware of how the disease is going to evolve (if it is a more aggressive or a slower evolution), the treatment is a decisive aspect.

A simple test could betray the presence of the three genetic defects which would allow doctors to prescribe a more aggressive treatment, which could eventually increase the survival rate of the patient. Statistics show that only 14% of those who have the three genetic defects live for more than 11 years, compared to 85% of those who do not present these three genetic defects.



Unfortunately, there are few patients who present all the three defective genes, according to an article published in the British Journal of Cancer. In Great Britain, from 308 subjects, only 6% presented all the three defective genes. According to Professor Colin Cooper, some prostate cancers evolve so slowly that they will never require treatment, and there are so aggressive types of prostate cancer that they become fatal in no time.